1. Market Research
  2. > IT Services
  3. > Hosting Market Trends
  4. > Reflux Esophagitis (Gastroesophageal Reflux Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Reflux Esophagitis (Gastroesophageal Reflux Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • January 2017
  • -
  • Delve Insight

Summary

Table of Contents


DelveInsight’s Report, “Reflux Esophagitis (Gastroesophageal Reflux Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Reflux Esophagitis (Gastroesophageal Reflux Disease) Report is to understand the market and pipeline status of the drugs around the Reflux Esophagitis (Gastroesophageal Reflux Disease) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Reflux Esophagitis (Gastroesophageal Reflux Disease). While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 48-72 Hours to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE:
- A snapshot of the global Market and Phase III therapeutics scenario for Reflux Esophagitis (Gastroesophageal Reflux Disease).
- A review of the marketed products under prescription for Reflux Esophagitis (Gastroesophageal Reflux Disease), regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Reflux Esophagitis (Gastroesophageal Reflux Disease) with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Reflux Esophagitis (Gastroesophageal Reflux Disease) drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Reflux Esophagitis (Gastroesophageal Reflux Disease) drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Reflux Esophagitis (Gastroesophageal Reflux Disease) drugs.
- Coverage of Reflux Esophagitis (Gastroesophageal Reflux Disease) Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure to 2018.

Reasons to buy:
- Evaluate the marketing status and exclusivity details of Reflux Esophagitis (Gastroesophageal Reflux Disease) key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Reflux Esophagitis (Gastroesophageal Reflux Disease).
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Reflux Esophagitis (Gastroesophageal Reflux Disease).
- API intelligence over marketed drugs forReflux Esophagitis (Gastroesophageal Reflux Disease)and gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III Pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Reflux Esophagitis (Gastroesophageal Reflux Disease).
- Uncovering opportunities in the rapidly growing US market.

Please note: this report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Data Center as a Bottleneck: Market Strategies, Analysis and Opportunities

Data Center as a Bottleneck: Market Strategies, Analysis and Opportunities

  • $ 19000
  • Industry report
  • January 2017
  • by WinterGreen Research

This 2017 module has 138 pages and 67 tables and figures Worldwide hyperscale data center markets implement cloud computing with shared resource and the aim, more or less achieved of providing foolproof ...

Field Service Management Market by Solution, Service, Deployment Type, User Type, Industry Vertical, and Region - Global Forecast to 2021

Field Service Management Market by Solution, Service, Deployment Type, User Type, Industry Vertical, and Region - Global Forecast to 2021

  • $ 7150
  • Industry report
  • March 2017
  • by MarketsandMarkets

“The growing need for a highly scalable centralized system for the management of field services is expected to drive the Field Service Management (FSM) market” The FSM market size is expected to grow ...

Cloud Service Brokerage Market and Large Enterprises - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Cloud Service Brokerage Market and Large Enterprises - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Cloud Service Brokerage Market: Overview Cloud service brokerage refers to an intermediary acting between a company or a third party and a potential customer of cloud computing service. Services ...

Top 10 Security Technologies

February 2017 $ 5650

Top 10 Cloud Technology Market

February 2017 $ 5650

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.